Skip to main content
Top
Published in: Breast Cancer Research 4/2008

Open Access 01-08-2008 | Research article

Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II

Authors: Heather Spencer Feigelson, Lauren R Teras, W Ryan Diver, Weining Tang, Alpa V Patel, Victoria L Stevens, Eugenia E Calle, Michael J Thun, Mark Bouzyk

Published in: Breast Cancer Research | Issue 4/2008

Login to get access

Abstract

Introduction

Obesity has consistently been associated with postmenopausal breast cancer risk. Proteins that are secreted by adipose tissue or are involved in regulating body mass may play a role in breast tumor development.

Methods

We conducted a nested case-control study among postmenopausal women from the American Cancer Society Cancer Prevention Study II Nutrition Cohort to determine whether genes associated with obesity increase risk for breast cancer. Tagging single nucleotide polymorphisms (SNPs) were selected to capture common variation across seven candidate genes that encode adipose-related proteins: ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1. Thirty-nine SNPs were genotyped in 648 cases and 659 controls. Logistic regression models were used to examine the association between each tagging SNP and risk for breast cancer while adjusting for matching factors and potential confounders. We also examined whether these SNPs were associated with measures of adult adiposity.

Results

Two out of five tagging SNPs in HSD11B1 were associated with breast cancer (rs11807619, P = 0.006; rs932335, P = 0.0001). rs11807619 and rs932335 were highly correlated (r 2 = 0.74) and, when modeled as a haplotype, only haplotypes containing the rs932335 C allele were associated with breast cancer. The rs932335 C allele was associated with a nearly twofold increased risk for breast cancer (odds ratio = 1.83, 95% confidence interval = 1.01–3.33 for C/C versus G/G). Three of the 11 SNPs for IRS2 were associated with breast cancer (rs4773082, P = 0.007; rs2289046, P = 0.016; rs754204, P = 0.03). When these three SNPs were examined as a haplotype, only the haplotype that included the G allele of rs2289046 was associated with breast cancer (odds ratio = 0.76, 95% confidence interval = 0.63–0.92 for TGC versus CAT). IRS2 rs2289046, rs754204, and rs12584136 were also associated with adult weight gain but only among cases. None of the other SNPs in any gene investigated were associated with breast cancer or adiposity.

Conclusion

Our findings suggest that these tagging SNPs in HSD11B1 and IRS2 mark regions of the genome that may harbor risk alleles for breast cancer, and these associations are probably independent of adiposity.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Cancer Research Fund: Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. 2007, Washington, DC: AICR World Cancer Research Fund: Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. 2007, Washington, DC: AICR
2.
go back to reference Calle E, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer. 2004, 4: 579-591. 10.1038/nrc1408.CrossRefPubMed Calle E, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer. 2004, 4: 579-591. 10.1038/nrc1408.CrossRefPubMed
3.
go back to reference Feigelson HS, Patel AV, Teras LR, Gansler T, Thun MJ, Calle EE: Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 2006, 107: 12-21. 10.1002/cncr.21965.CrossRefPubMed Feigelson HS, Patel AV, Teras LR, Gansler T, Thun MJ, Calle EE: Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 2006, 107: 12-21. 10.1002/cncr.21965.CrossRefPubMed
4.
go back to reference Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE: Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995, 87: 1297-1302. 10.1093/jnci/87.17.1297.CrossRefPubMed Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE: Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995, 87: 1297-1302. 10.1093/jnci/87.17.1297.CrossRefPubMed
5.
go back to reference Potischman N, Swanson C, Siiteri P, Hoover R: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996, 88: 756-758. 10.1093/jnci/88.11.756.CrossRefPubMed Potischman N, Swanson C, Siiteri P, Hoover R: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996, 88: 756-758. 10.1093/jnci/88.11.756.CrossRefPubMed
6.
go back to reference Huang XE, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwata H, Iwase T, Miura S, Mizuno T, Tokudome S, Tajima K: Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res. 2001, 3: 264-269. 10.1186/bcr304.CrossRefPubMedPubMedCentral Huang XE, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwata H, Iwase T, Miura S, Mizuno T, Tokudome S, Tajima K: Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res. 2001, 3: 264-269. 10.1186/bcr304.CrossRefPubMedPubMedCentral
7.
go back to reference McKean-Cowdin R, Li X, Bernstein L, McTiernan A, Ballard-Barbash R, Gauderman WJ, Gilliland F: The ADRB3 Trp64Arg variant and obesity in African-American breast cancer cases. Int J Obes (Lond). 2007, 31: 1110-1118. 10.1038/sj.ijo.0803554.CrossRef McKean-Cowdin R, Li X, Bernstein L, McTiernan A, Ballard-Barbash R, Gauderman WJ, Gilliland F: The ADRB3 Trp64Arg variant and obesity in African-American breast cancer cases. Int J Obes (Lond). 2007, 31: 1110-1118. 10.1038/sj.ijo.0803554.CrossRef
8.
go back to reference Slattery ML, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, Byers T: Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Res Treat. 2007, 104: 197-209. 10.1007/s10549-006-9403-9.CrossRefPubMed Slattery ML, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, Byers T: Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Res Treat. 2007, 104: 197-209. 10.1007/s10549-006-9403-9.CrossRefPubMed
9.
go back to reference Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, Schmutzler RK, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Försti A: Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis. 2006, 27: 1867-1875. 10.1093/carcin/bgl036.CrossRefPubMed Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, Schmutzler RK, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Försti A: Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis. 2006, 27: 1867-1875. 10.1093/carcin/bgl036.CrossRefPubMed
10.
go back to reference Wagner K, Hemminki K, Grzybowska E, Klaes R, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A: The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer. Carcinogenesis. 2004, 25: 2473-2478. 10.1093/carcin/bgh263.CrossRefPubMed Wagner K, Hemminki K, Grzybowska E, Klaes R, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A: The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer. Carcinogenesis. 2004, 25: 2473-2478. 10.1093/carcin/bgh263.CrossRefPubMed
11.
go back to reference Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S: Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1206-1214.PubMed Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S: Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1206-1214.PubMed
12.
go back to reference Skibola DR, Smith MT, Bracci PM, Hubbard AE, Agana L, Chi S, Holly EA: Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1251-1256. 10.1158/1055-9965.EPI-04-0895.CrossRefPubMed Skibola DR, Smith MT, Bracci PM, Hubbard AE, Agana L, Chi S, Holly EA: Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1251-1256. 10.1158/1055-9965.EPI-04-0895.CrossRefPubMed
13.
go back to reference Arcuri F, Sestini S, Ricci C, Runci Y, Carducci A, Paulesu L, Cintorino M: Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells. J Steroid Biochem Mol Biol. 2000, 72: 239-247. 10.1016/S0960-0760(00)00039-X.CrossRefPubMed Arcuri F, Sestini S, Ricci C, Runci Y, Carducci A, Paulesu L, Cintorino M: Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells. J Steroid Biochem Mol Biol. 2000, 72: 239-247. 10.1016/S0960-0760(00)00039-X.CrossRefPubMed
14.
go back to reference Cesarone G, Edupuganti OP, Chen CP, Wickstrom E: Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem. 2007, 18: 1831-1840. 10.1021/bc070135v.CrossRefPubMed Cesarone G, Edupuganti OP, Chen CP, Wickstrom E: Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem. 2007, 18: 1831-1840. 10.1021/bc070135v.CrossRefPubMed
15.
go back to reference Ma Z, Gibson SL, Byrne MA, Zhang J, White MF, Shaw LM: Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol. 2006, 26: 9338-9351. 10.1128/MCB.01032-06.CrossRefPubMedPubMedCentral Ma Z, Gibson SL, Byrne MA, Zhang J, White MF, Shaw LM: Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol. 2006, 26: 9338-9351. 10.1128/MCB.01032-06.CrossRefPubMedPubMedCentral
16.
go back to reference Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ: The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002, 94: 2490-2501. 10.1002/cncr.101970.CrossRefPubMed Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ: The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002, 94: 2490-2501. 10.1002/cncr.101970.CrossRefPubMed
19.
go back to reference Barrett J, Fry B, Maller J, Daly M: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed Barrett J, Fry B, Maller J, Daly M: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed
20.
go back to reference de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet. 2005, 37: 1217-1223. 10.1038/ng1669.CrossRefPubMed de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet. 2005, 37: 1217-1223. 10.1038/ng1669.CrossRefPubMed
22.
go back to reference Stram D, Haiman C, Hirschhorn J, Altshuler D, Kolonel L, Henderson B, Pike M: Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered. 2003, 55: 27-36. 10.1159/000071807.CrossRefPubMed Stram D, Haiman C, Hirschhorn J, Altshuler D, Kolonel L, Henderson B, Pike M: Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered. 2003, 55: 27-36. 10.1159/000071807.CrossRefPubMed
23.
go back to reference Feigelson H, Jonas C, Teras L, Thun M, Calle E: Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004, 13: 220-224. 10.1158/1055-9965.EPI-03-0301.CrossRefPubMed Feigelson H, Jonas C, Teras L, Thun M, Calle E: Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004, 13: 220-224. 10.1158/1055-9965.EPI-03-0301.CrossRefPubMed
24.
go back to reference Huang Z, Hankinson S, Colditz G, Stampfer M, Hunter D, Manson J, Hennekens C, Rosner B, Speizer F, Willett W: Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997, 278: 1407-1411. 10.1001/jama.278.17.1407.CrossRefPubMed Huang Z, Hankinson S, Colditz G, Stampfer M, Hunter D, Manson J, Hennekens C, Rosner B, Speizer F, Willett W: Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997, 278: 1407-1411. 10.1001/jama.278.17.1407.CrossRefPubMed
25.
go back to reference Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, Walker BR: Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91: 2295-2302. 10.1210/jc.2005-2222.CrossRefPubMed Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, Walker BR: Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91: 2295-2302. 10.1210/jc.2005-2222.CrossRefPubMed
26.
go back to reference Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF, Hoover RN, Thomas G, Chanock SJ: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007, 39: 870-874. 10.1038/ng2075.CrossRefPubMedPubMedCentral Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF, Hoover RN, Thomas G, Chanock SJ: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007, 39: 870-874. 10.1038/ng2075.CrossRefPubMedPubMedCentral
28.
go back to reference Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D'Agostino RB, Atwood LD: Genomewide linkage analysis of weight change in the Framingham Heart Study. J Clin Endocrinol Metab. 2005, 90: 3197-3201. 10.1210/jc.2004-1752.CrossRefPubMed Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D'Agostino RB, Atwood LD: Genomewide linkage analysis of weight change in the Framingham Heart Study. J Clin Endocrinol Metab. 2005, 90: 3197-3201. 10.1210/jc.2004-1752.CrossRefPubMed
29.
go back to reference Smit P, Dekker MJ, de Jong FJ, Beld van den AW, Koper JW, Pols HA, Brinkmann AO, de Jong FH, Breteler MM, Lamberts SW: Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia. J Clin Endocrinol Metab. 2007, 92: 359-362. 10.1210/jc.2006-1349.CrossRefPubMed Smit P, Dekker MJ, de Jong FJ, Beld van den AW, Koper JW, Pols HA, Brinkmann AO, de Jong FH, Breteler MM, Lamberts SW: Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia. J Clin Endocrinol Metab. 2007, 92: 359-362. 10.1210/jc.2006-1349.CrossRefPubMed
30.
go back to reference Lautier C, ElMkadem S, Renard E, Brun J, Gris J, Bringer J, Grigorescu F: Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet. 2003, 113: 34-43.PubMed Lautier C, ElMkadem S, Renard E, Brun J, Gris J, Bringer J, Grigorescu F: Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet. 2003, 113: 34-43.PubMed
31.
go back to reference Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Wolff R, Caan BJ, Slattery ML: Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1802-1809. 10.1158/1055-9965.EPI-05-0149.CrossRefPubMed Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Wolff R, Caan BJ, Slattery ML: Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1802-1809. 10.1158/1055-9965.EPI-05-0149.CrossRefPubMed
32.
go back to reference Saunders CL, Chiodini BD, Sham P, Lewis CM, Abkevich V, Adeyemo AA, de Andrade M, Arya R, Berenson GS, Blangero J, Boehnke M, Borecki IB, Chagnon YC, Chen W, Comuzzie AG, Deng HW, Duggirala R, Feitosa MF, Froguel P, Hanson RL, Hebebrand J, Huezo-Dias P, Kissebah AH, Li W, Luke A, Martin LJ, Nash M, Ohman M, Palmer LJ, Peltonen L, et al: Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity (Silver Spring). 2007, 15: 2263-2275. 10.1038/oby.2007.269.CrossRef Saunders CL, Chiodini BD, Sham P, Lewis CM, Abkevich V, Adeyemo AA, de Andrade M, Arya R, Berenson GS, Blangero J, Boehnke M, Borecki IB, Chagnon YC, Chen W, Comuzzie AG, Deng HW, Duggirala R, Feitosa MF, Froguel P, Hanson RL, Hebebrand J, Huezo-Dias P, Kissebah AH, Li W, Luke A, Martin LJ, Nash M, Ohman M, Palmer LJ, Peltonen L, et al: Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity (Silver Spring). 2007, 15: 2263-2275. 10.1038/oby.2007.269.CrossRef
Metadata
Title
Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II
Authors
Heather Spencer Feigelson
Lauren R Teras
W Ryan Diver
Weining Tang
Alpa V Patel
Victoria L Stevens
Eugenia E Calle
Michael J Thun
Mark Bouzyk
Publication date
01-08-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 4/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2114

Other articles of this Issue 4/2008

Breast Cancer Research 4/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine